Stockscreener 앱 받기
27.81
2.92%
0.79
시간 외 거래:
27.81
Bicara Therapeutics Inc 주식(BCAX)의 최신 뉴스
BlackRock (BCAX holder) discloses 5.4% Bicara Therapeutics stake on Schedule 13G - Stock Titan
Bicara Therapeutics Inc (BCAX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bicara Therapeutics Inc (BCAX) Balance Sheet - TradingKey
Bicara Therapeutics Inc (BCAX) Income Statement - TradingKey
Bicara Therapeutics Inc (BCAX) Cash Flow - TradingKey
Bicara Therapeutics Inc (BCAX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bicara Therapeutics Inc (BCAX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BCAX|Bicara Therapeutics Inc|Price:27.020|Chg%:-0.710 - TradingKey
Bicara Therapeutics Inc (BCAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bicara Therapeutics (BCAX) Hovers Near Support Amid Modest DeclineProfit Surge Picks - dars.gov.et
Bicara Therapeutics (BCAX) Corporate presentation Summary - Quartr
Bicara Therapeutics (BCAX) Proxy filing Summary - Quartr
Bicara Therapeutics (BCAX) Study update Summary - Quartr
Bicara Therapeutics (BCAX) Q1 2026 earnings summary - Quartr
Form 4 Bicara Therapeutics Inc For: 14 July By Investing.com - Investing.com South Africa
Bicara Therapeutics CEO Claire Mazumdar disposes of $284k in stock - Investing.com Nigeria
Bicara Therapeutics CEO Claire Mazumdar disposes of $284k in stock By Investing.com - Investing.com India
Form 4 Bicara Therapeutics Inc For: 14 July - Investing.com India
Bicara Therapeutics (BCAX) CEO exercises options and sells 10,000 shares under 10b5-1 plan - Stock Titan
Enterprise value to revenue forward of Bicara Therapeutics Inc. – NASDAQ:BCAX - TradingView
Extended Trial Data And Insider Sale Could Be A Game Changer For Bicara Therapeutics (BCAX) - Sahm
Bicara therapeutics president & COO sells $833k in stock By Investing.com - Investing.com India
Bicara Therapeutics CFO Hyep Ivan sells $807k in stock By Investing.com - Investing.com India
Form 144 Bicara Therapeutics Inc. For: 10 July By Investing.com - Investing.com Nigeria
Enterprise value to EBIT forward of Bicara Therapeutics Inc. – NASDAQ:BCAX - TradingView
Form 4 Bicara Therapeutics Inc For: 10 July By Investing.com - Investing.com South Africa
Bicara Therapeutics CFO Hyep Ivan sells $807k in stock - Investing.com
Bicara therapeutics president & COO sells $833k in stock - Investing.com
Bicara Therapeutics Insider Sold Shares Worth $833,129, According to a Recent SEC Filing - marketscreener.com
[Form 4] Bicara Therapeutics Inc. Insider Trading Activity - Stock Titan
Bicara Therapeutics (BCAX) COO exercises options, sells 28,750 shares under plan - Stock Titan
Price to sales forward of Bicara Therapeutics Inc. – BOATS:BCAX - TradingView
Price to book forward of Bicara Therapeutics Inc. – NASDAQ:BCAX - TradingView
Form 144 BICARA THERAPEUTICS INC. For: 8 July By Investing.com - Investing.com Nigeria
Form 144 Bicara Therapeutics Inc. For: 8 July By Investing.com - Investing.com Nigeria
BCAX (NASDAQ) insider sales: 50,000-share option exercise set for 07/08/2026 - Stock Titan
Sale notice: 28,750 shares disclosed by BCAX (NASDAQ: BCAX) - Stock Titan
BCAX (NASDAQ) affiliate files Rule 144; past sales of 9,200 shares noted - Stock Titan
Bicara Therapeutics (BCAX) Piper Sandler 37th Annual Healthcare Conference Summary - Quartr
Form 144 BICARA THERAPEUTICS INC. For: 7 July By Investing.com - Investing.com Nigeria
1.97%
0.83%
자본화:
|
볼륨(24시간):